These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22316639)

  • 1. Psychotropic drug-induced weight gain and other metabolic complications in a Swiss psychiatric population.
    Choong E; Bondolfi G; Etter M; Jermann F; Aubry JM; Bartolomei J; Gholam-Rezaee M; Eap CB
    J Psychiatr Res; 2012 Apr; 46(4):540-8. PubMed ID: 22316639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].
    Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN
    Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
    Koga M
    Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
    Limosin F; Gasquet I; Leguay D; Azorin JM; Rouillon F
    Acta Psychiatr Scand; 2008 Jul; 118(1):19-25. PubMed ID: 18582344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.
    Baptista T; Kin NM; Beaulieu S; de Baptista EA
    Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribing patterns and the use of therapeutic drug monitoring of psychotropic medication in a psychiatric high-security unit.
    Castberg I; Spigset O
    Ther Drug Monit; 2008 Oct; 30(5):597-603. PubMed ID: 18708990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric medication-induced obesity: a review.
    Schwartz TL; Nihalani N; Jindal S; Virk S; Jones N
    Obes Rev; 2004 May; 5(2):115-21. PubMed ID: 15086865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does obesity lead to a specific lipid disorder? Analysis from the German/Austrian/Swiss APV registry.
    Holl RW; Hoffmeister U; Thamm M; Stachow R; Keller KM; L'Allemand D; Widhalm K; Flechtner-Mors M; Wiegand S
    Int J Pediatr Obes; 2011 Sep; 6 Suppl 1():53-8. PubMed ID: 21905817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight considerations in psychotropic drug prescribing and switching.
    Hasnain M; Vieweg WV
    Postgrad Med; 2013 Sep; 125(5):117-29. PubMed ID: 24113670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, psychiatric status, and psychiatric medications.
    Berkowitz RI; Fabricatore AN
    Psychiatr Clin North Am; 2005 Mar; 28(1):39-54, vii-viii. PubMed ID: 15733610
    [No Abstract]   [Full Text] [Related]  

  • 12. Weight changes and their associations with demographic and clinical characteristics in risperidone maintenance treatment for schizophrenia.
    Xiang YT; Wang CY; Ungvari GS; Kreyenbuhl JA; Chiu HF; Lai KY; Lee EH; Bo QJ; Dixon LB
    Pharmacopsychiatry; 2011 Jun; 44(4):135-41. PubMed ID: 21710403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Schizophrenia, obesity and pharmacotherapy-associated weight gain].
    Carpiniello B; Corda E; Maccioni R; Pinna F
    Clin Ter; 2008; 159(5):299-306. PubMed ID: 18998030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study.
    Bjorvatn B; Sagen IM; Øyane N; Waage S; Fetveit A; Pallesen S; Ursin R
    J Sleep Res; 2007 Mar; 16(1):66-76. PubMed ID: 17309765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
    Misra KB; Endemann SW; Ayer M
    Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index and obesity in adolescents in a psychiatric medium secure service.
    Haw C; Bailey S
    J Hum Nutr Diet; 2012 Apr; 25(2):167-71. PubMed ID: 21585567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic options for weight management in schizophrenic patients treated with atypical antipsychotics].
    Cordes J; Sinha-Röder A; Kahl KG; Malevani J; Thuenker J; Lange-Asschenfeldt C; Hauner H; Agelink MW; Klimke A
    Fortschr Neurol Psychiatr; 2008 Dec; 76(12):703-14. PubMed ID: 18924059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic drug use in psychiatric inpatients: recent trends and changes over time-data from the AMSP study.
    Grohmann R; Engel RR; Geissler KH; Rüther E
    Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S27-38. PubMed ID: 15052512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight changes in teens on psychotropic medication combinations at Austin State Hospital.
    Becker EA; Shafer A; Anderson R
    Tex Med; 2005 Mar; 101(3):62-70. PubMed ID: 16134805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.
    Vandenberghe F; Gholam-Rezaee M; Saigí-Morgui N; Delacrétaz A; Choong E; Solida-Tozzi A; Kolly S; Thonney J; Gallo SF; Hedjal A; Ambresin AE; von Gunten A; Conus P; Eap CB
    J Clin Psychiatry; 2015 Nov; 76(11):e1417-23. PubMed ID: 26646038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.